CanG
CanG · page 2
- Legal Analysis
Germany’s Medical Market Continues Record Growth in the Face of Clampdown
The blistering growth of Germany’s medical cannabis sector showed no signs of abating through the second quarter of 2025, with imports rising another 15% to hit new records.
- Legal Analysis
Seizures of Cannabis Smuggled Into Germany Have Risen 50% Despite Reforms
You can also read this story in German, here. When the Cannabis Act came into force in Germany, the aim was to improve the country’s drug policy by changing the way the popular recreational drug was handled.
- Industry Trends
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond.
- UK & Europe
Germany’s Cannabis Social Clubs Stuck in Bureaucratic Gridlock One Year After Partial Legalisation
It was the goal of the previous German coalition government to protect the health of patients and consumers by legalising cannabis, ensuring better protection of minors and diversion from black market trade thanks to legal alternatives.
- US & Canada
The New Federal Government Drugs Commissioner Remains Vague on the Cannabis Issue
With the appointment of Prof. Dr. Hendrik Streeck as the new Federal Government Commissioner for Drugs, Burkhard Blienert had to say goodbye to this post, seeing a supporter of legalisation replaced by a scientist who became well-known during the coronavirus pandemic take the helm in drug policy in Germany.
- Uncategorized
What Can the UK Learn From Germany’s Booming Medical Cannabis Market?
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
- Adult-Use
German Cannabis Law Remains Uncertain, Malta Imposes Controversial Changes, Dutch Cannabis Experiment Progresses, & More from Czech Republic
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
- Data & Analysis
What Impact Has Partial Cannabis Legalisation Had on Germany One Year On?
Since April 01 2024, hundreds of millions of Euros have been invested into the German medical cannabis sector, hundreds of thousands of criminal proceedings have been avoided, and millions of citizens have enjoyed free and legal access to cannabis for the first time.
- Medical
Will Germany’s Medical Cannabis Boom Survive the February Election?
A month out from Germany’s federal election, alarm bells are ringing for the booming cannabis market.
- Medical
Medical or Recreational? Bedrocan Calls for Stricter Medical Market Regulation From New German Government
The increasingly blurry lines between Germany’s medical and recreational cannabis markets are continuing to cause conflict among lawmakers and industry stakeholders ahead of the upcoming general election.
- Events
Shaping Germany’s Cannabis Future: Insights from the Berlin Executive Summit
Last week, the Business of Cannabis: Berlin Executive Summit welcomed over 150 executives, policymakers, and thought leaders to take stock of how the first eight months of Germany’s landmark CanG bill had impacted the market and discuss how the uncertain future could play out.
- Policy & Regulation
Germany’s Poll-Leading Party Eyes Rollback of Cannabis Reforms as Elections Loom
While little common ground was found during Friday’s debate, the well-trodden rhetoric from each side emphasised that the implementation of CanG remains a controversial and divisive issue in Germany.
